newsfilter
← Latest News
GlobeNewswire·

Antares Pharma Initiates Phase I Study For ATRS-1902 For Adrenal Crisis Rescue

EWING, N.J., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) ("the Company"), a specialty pharmaceutical company, today announced that it has initiated a Phase 1 study for ATRS-1902 for adrenal crisis rescue. The development progr